Fortis Healthcare Schedules Board Meeting and Conference Call for Q3FY26 Results
Fortis Healthcare Limited has announced comprehensive arrangements for Q3FY26 financial results presentation, including a board meeting on February 13, 2026, and a subsequent conference call on February 16, 2026, at 11:00 AM IST with detailed dial-in information for domestic and international participants.

*this image is generated using AI for illustrative purposes only.
Fortis Healthcare Limited has formally notified stock exchanges about comprehensive arrangements for its quarterly financial performance review. The healthcare major will present its third-quarter results to investors and stakeholders through multiple engagement channels following regulatory compliance procedures.
Board Meeting Details
The company has scheduled a Board of Directors meeting for Friday, February 13, 2026, with a specific agenda to consider and approve crucial financial documents. The meeting will focus on reviewing comprehensive financial performance across different business segments.
| Meeting Parameter: | Details |
|---|---|
| Date: | February 13, 2026 |
| Purpose: | Consider and approve Q3FY26 unaudited financial results |
| Reporting Period: | Quarter and period ended December 31, 2025 |
| Results Type: | Standalone and Consolidated |
Conference Call Schedule
Following the board meeting, Fortis Healthcare Limited has arranged a conference call to discuss the financial results with investors and analysts. The virtual meeting will provide detailed insights into the company's quarterly and nine-month performance.
| Conference Call Details: | Information |
|---|---|
| Date: | February 16, 2026 |
| Time: | 11:00 AM IST |
| Mode: | Virtual Conference Call |
| Purpose: | Discuss Q3FY26 and 9MFY26 unaudited financial results |
| Type: | Group Call |
Dial-in Information
The company has provided comprehensive dial-in details for both domestic and international participants to ensure broad accessibility for the conference call.
| Participant Region: | Dial-in Number | Local Time |
|---|---|---|
| India Primary: | +91 22 6280 1307 / 7115 8208 | 11:00 AM |
| UK (Toll Free): | 0 808 101 1573 | 05:30 AM |
| US NY (Toll Free): | 1 866 746 2133 | 12:30 AM |
| Singapore (Toll Free): | 800 101 2045 | 01:30 PM |
| Hong Kong (Toll Free): | 800 964 448 | 01:30 PM |
Trading Window Restrictions
In accordance with regulatory compliance requirements, Fortis Healthcare Limited has implemented mandatory trading restrictions for company securities. The trading window closure ensures fair market practices during the financial results announcement period.
| Trading Window Details: | Information |
|---|---|
| Status: | Closed |
| Duration: | Until 48 hours after results announcement |
| Closure End Date: | February 15, 2026 |
| Reference Letter: | FHL/SEC/2025-26 dated December 22, 2025 |
Regulatory Compliance
The board meeting and conference call notifications have been issued in strict compliance with Securities and Exchange Board of India regulations. The company has fulfilled its disclosure obligations under multiple regulatory frameworks to ensure transparency in corporate governance. The notifications were filed under Regulation 29, 30, and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.09% | +1.69% | -6.44% | -1.32% | +27.89% | +411.31% |


































